LabCompass

C. D. Bloomfield

Medicine · The Ohio State University

Established · publishing since 1974

Publications

73

Citations

16,778

Est. group size

Recurring co-author estimate

Active years

52

Publishing since 1974

Research summary
AI-generated

C. D. Bloomfield's research focuses on blood cancers, particularly acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). This work includes studying genetic markers that help predict how patients will respond to treatment, such as gene mutations (NPM1/FLT3-ITD) and genetic variations affecting drug side effects. The research aims to improve how doctors classify leukemia patients by risk level and select appropriate therapies.

Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid LeukemiaLymphomaChronic Lymphocytic Leukemia

Publication output over the last decade has been very sparse, with only two publications recorded (in 2019 and 2025) and no consistent yearly output.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 0.2/year recently
17182019: 1 publication11920212223242025: 1 publication12526
Publishes in
  • The Pharmacogenomics Journal×1
  • Haematologica×1
  • Cancer×1
  • HemaSphere×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile